2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
NET
58
Gastrointestinal
58
Endocrine
58
Thoracic
4
Sarcoma
4
CNS
4
Other solid neoplasm
2
Lymphoid
2
Head & Neck
2
Gynecologic
2
Breast
2
Genitourinary
1
Dermatologic
1
Conditions
Lymphoma
2982
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2499
Lymphoma, Non-Hodgkin
2268
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Lymphoma, Follicular
1847
Lymphoma, Large B-Cell, Diffuse
1785
Leukemia
1341
Hodgkin Disease
1293
Lymphoma, Mantle-Cell
1193
Leukemia, Myeloid, Acute
979
Burkitt Lymphoma
956
Multiple Myeloma
866
Lymphoma, B-Cell, Marginal Zone
853
Recurrence
841
Lymphoma, B-Cell
756
Myelodysplastic Syndromes
683
Neoplasms
595
Lymphoma, T-Cell, Cutaneous
543
Waldenstrom Macroglobulinemia
514
Lymphoma, Large-Cell, Immunoblastic
490
Mycosis Fungoides
438
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
414
Lymphoma, Large-Cell, Anaplastic
390
Sezary Syndrome
364
Lymphoma, T-Cell, Peripheral
352
Hematologic Neoplasms
351
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
334
Myeloproliferative Disorders
328
Neoplasms, Plasma Cell
309
Blast Crisis
284
Interventions
pasireotide
1
amino-acid, glucose, and electrolyte solution
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Lymphoid
×
Clear all
NCT06441331
2026-05-01
KinLET
ITM Solucin GmbH
Phase 1
Recruiting
20 enrolled
NCT06784752
2026-04-30
NETTER-3
Novartis
Phase 3
Recruiting
240 enrolled